Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medbright AI Investments Inc C.MBAI

Alternate Symbol(s):  MBAIF

MedBright AI Investments Inc. is a capital allocator focused on investing in healthcare technology companies. The Company is engaged in constructing a portfolio of synergistic investments to generate returns for shareholders. The Company is focused on significant near-term and midterm opportunities with potential returns while maintaining a commitment to governance. It is focused on investing in technology and artificial intelligence companies, combined with healthcare operators.


CSE:MBAI - Post by User

Post by 1StockInformeron Nov 23, 2023 5:45pm
86 Views
Post# 35750712

Revolutionizing Healthcare Efficiency through AI

Revolutionizing Healthcare Efficiency through AI

In the realm of the burgeoning AI revolution, discerning investors face the formidable task of identifying intelligent solutions within the open market. A recent addition that has piqued interest is MedBright AI Investments (Ticker: MBAI.c or MBAIF for US investors), an entity that stands at the forefront of innovative AI-driven solutions for efficient healthcare. 


MedBright AI operates on the cutting edge with its platform, "Medmatrix," utilizing the power of AI and historical data encompassing medical, credit card, and driving records. 


This amalgamation of data enables the platform to predict the optimal length of appointments for clinic patients, thereby facilitating the creation of a more refined and efficient schedule for doctors and a heightened experience for patients. 


This solution addresses a significant challenge in healthcare, particularly the inefficiencies inherent in doctor's waiting rooms, making it a noteworthy venture.

User image


The potential impact of MedBright AI Investments extends far beyond immediate gains. In the vast healthcare market, valued at $2.2 trillion, the "Medmatrix" platform is estimated to increase efficiency by 10%, presenting a substantial $220 billion opportunity.


The timing of this solution aligns with a critical juncture in AI capabilities, as it has now reached the level of processing vast datasets to simulate and make accurate predictions, rendering such a solution previously unattainable.


Notable industry connections further fortify MedBright AI Investments' standing. Yesterday MedBright shared that Michael Dalsin, the Chair of the company, is set to participate in medical economics lectures at Yale University School of Medicine, underscoring the company's commitment to advancing healthcare through AI. 


The collaboration with The Ken Sperling Lecture Series, focusing on healthcare microeconomics and the impact of AI on healthcare services in the U.S., solidifies MedBright AI Investments' dedication to contributing to the evolution of healthcare.


Click here for the full story: https://www.accesswire.com/viewarticle.aspx?id=808219&lang=en

Or here to check out MedBright's newly posted investors' deck: https://assets-global.website-files.com/654400b037e09f716a28c32b/655f911132d0b133ffc9ca1c_Medbright%20Q4%202023%20Investor%20Presentation.pdf


Posted on behalf of MedBright AI Investments Inc.

 
<< Previous
Bullboard Posts
Next >>